Early real-world utilization of ADA-adaz (Hyrimoz) in the United States: A retrospective claims-based descriptive study.

Chen A, Bungay R, Gagnon-Sanschagrin P, Bedard J, Gobeil N, Guerin A, Li E

Open source

DOI
10.1097/md.0000000000050452
Published
2026 Aug 28
Container
Medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/md.0000000000050452,
  title = {Early real-world utilization of ADA-adaz (Hyrimoz) in the United States: A retrospective claims-based descriptive study.},
  author = {Chen A and Bungay R and Gagnon-Sanschagrin P and Bedard J and Gobeil N and Guerin A and Li E},
  year = {2026},
  journal = {Medicine},
  doi = {10.1097/md.0000000000050452},
  url = {https://doi.org/10.1097/md.0000000000050452}
}

RIS

TY  - JOUR
TI  - Early real-world utilization of ADA-adaz (Hyrimoz) in the United States: A retrospective claims-based descriptive study.
AU  - Chen A
AU  - Bungay R
AU  - Gagnon-Sanschagrin P
AU  - Bedard J
AU  - Gobeil N
AU  - Guerin A
AU  - Li E
PY  - 2026
JO  - Medicine
DO  - 10.1097/md.0000000000050452
UR  - https://doi.org/10.1097/md.0000000000050452
ER  - 

APA

A, C., R, B., P, G., J, B., N, G., A, G., & E, L. (2026). Early real-world utilization of ADA-adaz (Hyrimoz) in the United States: A retrospective claims-based descriptive study.. Medicine. https://doi.org/10.1097/md.0000000000050452

Source records